Loading...
Liminatus Pharma, Inc. Class A Common Stock
LIMN•NASDAQ
Healthcare
Biotechnology
$16.60
$-7.38(-30.78%)
Liminatus Pharma, Inc. Class A Common Stock (LIMN) Executive Leadership & Compensation
Meet the executive team behind Liminatus Pharma, Inc. Class A Common Stock, including their roles, responsibilities, and compensation insights
LIMN - Key Executive Compensation Overview
Detailed breakdown of executive salaries, stock awards, bonuses, and leadership positions.